HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing (Health)

Set Alert for Marketing {Health}

Product Launches

Set Alert for Launches {Health}

Latest From Health & Launches

OTC Marketing Awards 2022: What The Judges Said About The Leading Entries

The trophies have been handed out at the OTC Marketing Awards 2022 - but what did the expert judges have to say about the winning and highly-commended entries?

Innovation Ad Campaigns

Haleon Voted Company Of The Year At The OTC Marketing Awards 2022

Winners across 15 categories were announced at the OTC Marketing Awards 2022 on 28 November, with Haleon crowned OTC Company of the Year.

Ad Campaigns Launches

Bayer Extends Afrin Line With First OTC Oxymetazoline Spray In US For Children Under 6

Children’s Afrin regular and no-drip formulations reach US stores with consumers having choices between dozens of oxymetazoline nasal sprays available under an FDA OTC monograph. But products indicated for children was limited to one, Mucinex Childrens Stuffy Nose, and it’s for children 6 and up.

OTC Drugs Launches
See All

Advertising Campaigns

Set Alert for Ad Campaigns {Health}

Latest From Health & Ad Campaigns

OTC Marketing Awards 2022: What The Judges Said About The Leading Entries

The trophies have been handed out at the OTC Marketing Awards 2022 - but what did the expert judges have to say about the winning and highly-commended entries?

Innovation Ad Campaigns

Haleon Voted Company Of The Year At The OTC Marketing Awards 2022

Winners across 15 categories were announced at the OTC Marketing Awards 2022 on 28 November, with Haleon crowned OTC Company of the Year.

Ad Campaigns Launches

UK Pharmacies Recommending Short-Term Treatments Over PPIs For Frequent Heartburn – Haleon Survey

Haleon data shows a notable increase in UK pharmacy teams recommending PPIs for frequent heartburn in the year ended September 2022. However, pharmacies are still recommending alginate-based OTCs and antacids over PPIs for frequent heartburn in the majority of occasions, which Haleon says points to a need for more pharmacy education.

United Kingdom Health
See All

Advertising Enforcement

Set Alert for Ad Complaints {Health}

Latest From Health & Ad Complaints

On J&J Challenge, Review Finds Nothing Funny In Genexa’s ‘Real Ingredients’ Comparison To Tylenol

Genexa appeals NAD recommendations to stop using or modify claims that make up the core of its advertising to differentiate its products. NAD reviewed ad claims for Genexa kids’ Pain & Fever acetaminophen product on a challenge by J&J.

Ad Complaints Enforcement

Genexa Continues ‘Clean Medicine’ Mission With Guafenesin For Adults Launch

Launch comes six months after Genexa launched Acetaminophen Extra Strength and Acetaminophen PM caplets with “same active ingredients and dosages of current category leaders but without artificial dyes, synthetic fillers and other artificial preservatives,” and seven months after it was named to Fast Company’s annual list of the World’s Most Innovative Companies for 2022.

OTC Drugs Launches

Perrigo's Evidence For Nasal Spray Claims Not Enough For ASA

Ad claims that Perrigo’s BecoCleanse could protect against viruses to help prevent the occurrence of cold symptoms were not supported by sufficient evidence, the UK’s Advertising Standards Authority has ruled.

Ad Complaints OTC Devices
See All
UsernamePublicRestriction

Register